Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: Kirsty Hartley was sentenced Thursday. The sentence includes 18 months of house arrest. U.S. Attorney Stephen McAllister says Hartley's husband, Dalton Hartley, was given the same sentence because he received the drugs from her. Kirsty Hartley pleaded guilty to distributing a prescription painkiller outside the usual course of professional practice. Dalton Hartley pleaded guilty acquiring controlled substances through fraud. Kirsty Hartley worked at a CVS pharmacy. She admitted she gave more than 21,000 tablets of hydrocodone with acetaminophen to her husband. He consumed or traded them for marijuana. As part of her plea, Kirsty Hartley surrendered her pharmacist's license. Claim: Salina pharmacist, husband sentenced in opioid diversion.
Example Output: A 29-year-old Salina pharmacist has been sentenced to three years of probation for diverting prescription drugs containing opioids.

Example Input: Paragraph: The deal would resolve alleged violations of civil environmental statutes, including the Clean Water Act, related to the pollution from a company factory in Waynesboro. It would amount to the largest environmental damage settlement in Virginia history and the eighth largest in the nation, officials said. The money would go to projects including wildlife habitat restoration, water quality enhancement and improvements to recreational areas. "In bringing this settlement to a close, we are finally righting a wrong that has impacted the South River and the South Fork of the Shenandoah River for so many decades," Democratic Gov. Terry McAuliffe said at a news conference announcing the settlement. Wilmington, Delaware-based Dupont Co. used mercury in its process of making synthetic fiber at the plant between 1929 and 1950, according to the state Department of Environmental Quality. Strict storage and disposal regulations weren't in place at the time, and some of the mercury seeped into the South River and flowed downstream to the South Fork of the Shenandoah River. DuPont discovered the mercury which accumulates in fish and is especially dangerous to pregnant or breastfeeding women and young children in the facility's soil in 1976, officials say. The pollution impacted over 100 miles of river and thousands of acres of floodplain and riparian habitat, affecting fish, mussels, migratory birds and amphibians, the Department of Justice said in a statement. The pollution also has limited some recreational fishing in Waynesboro, a city of about 20,000 in the Shenandoah Valley. The terms of the settlement are outlined in a proposed consent decree that was filed in federal court in Harrisonburg on Thursday. It is subject to a 45-day public comment period and must be approved by the court. The amount of money proposed is "quite impressive," but mercury is very persistent in the environment and very difficult to remove, said Dr. Thomas Benzing, a professor of integrated science and technology at James Madison University who works with a team of researchers who have been monitoring the mercury levels since 2001. If the settlement goes forward, DuPont would pay slightly more than $42 million toward projects including streamside plantings and erosion control to improve water quality and fish habitat; mussel propagation and restoration; migratory songbird habitat restoration and protection; and recreational fishing access creation or improvement. The company also will pay for renovations at the Front Royal Fish Hatchery to improve production of warm-water fish such as smallmouth bass, at an estimated cost of up to $10 million. "Every dollar is going to be used to clean up the land, the source issues and the water, to where it would have been" if not for the pollution, said Assistant Attorney General John Cruden of the Justice Department's Environmental and Natural Resources Division. No one from DuPont which is awaiting final regulatory approval for its merger with Dow Chemical in a deal to create DowDuPont, a $130 billion conglomerate spoke at the announcement. But Mike Liberati, South River project director for the DuPont Corporate Remediation Group, said in a statement that DuPont "is committed to a long-term presence in the Waynesboro area and to maintaining transparency with its citizens." The first phase of remediation, involving part of the riverbank in Waynesboro's Constitution Park could be complete in February. Soil there containing the highest concentrations of mercury is being excavated and hauled away and replaced by clean topsoil, Liberati said. "It's going to be a long-term project. It's not something that's going to happen overnight," Benzing said. Claim: DuPont to pay $50M over mercury-contaminated Virginia rivers.
Example Output: Chemical giant DuPont will pay more than $50 million but admit no fault under a proposed environmental settlement after releasing toxic mercury for decades that made its way into Shenandoah Valley waterways, state and federal officials announced Thursday.

Example Input: Paragraph: The settlement, the largest by any company related to the U.S. opioid epidemic, resolved long-running probes by the U.S. Justice Department and the Federal Trade Commission into the companies' marketing and sales of Suboxone Film. The deal came after Indivior in April was indicted and accused of deceiving doctors and healthcare benefit programs into believing Suboxone Film, itself a form of opioid, was safer and less susceptible to abuse than similar drugs. The indictment said Indivior also used an internet and telephone program touted as a resource for opioid-addicted patients to connect them to doctors it knew were prescribing Suboxone and other opioids at high rates and in suspect circumstances. The Justice Department said the scheme began before Indivior spun out of Reckitt in 2014 and resulted in thousands of opioid-addicted patients using the drug. Opioids, including prescription painkillers and heroin, played a role in a record 47,600 U.S. overdose deaths in 2017, the U.S. Centers for Disease Control and Prevention has said. Reckitt was not indicted like Indivior, but the department last year joined several whistleblower lawsuits alleging the British company improperly marketed the drug. As part of Thursday's settlement, Reckitt entered into a non-prosecution agreement and agreed to pay nearly $1.35 billion to resolve the Justice Department's criminal and civil claims. It will also pay $50 million to resolve FTC claims that it engaged in anticompetitive activities aimed at impeding competition from generic versions of Suboxone. Reckitt said in a statement that it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct." But it said its board had decided the settlement was in the company's best interests. Slough, England-based Indivior has pleaded not guilty to conspiracy and fraud charges. In a statement, it acknowledged Reckitt's settlement but said it had no new information on the case. Its trial in federal court in Abingdon, Virginia is set for May. (GRAPHIC - Reckitt gains in value after Indivior spin-off: tmsnrt.rs/2NPlAJJ) Shares in Reckitt, whose products range from Mucinex cold medicine and Lysol cleaners, closed up 2.5%. While the settlement is significantly higher than the $400 million that the consumer goods group had set aside to cover the cost of the investigations, analysts said it could allow the company's new chief executive to focus on a turnaround plan. In an effort to regain investor confidence after setbacks including a safety scandal in South Korea, a failed product launch and a cyber attack, Reckitt's outgoing boss Rakesh Kapoor launched a plan to split the group into two business units one for health and one for hygiene and home products. Investors had feared the U.S. probes could hinder the transformation. Analysts at JP Morgan wrote in a note that settlement "clarifies the legal environment for RB and should allow the new management to focus on the RB 2.0 transformation." While welcoming the settlement, AJ Bell investment director Russ Mould said the cost could limit incoming CEO Laxman Narasimhan's ability to undertake much-needed investment in Reckitt's brands. "The danger is that Narasimhan will be operating with one hand tied behind his back," he said. The company said it would increase its provision related to the investigations to $1.5 billion to cover both the cost of the settlement and "any remaining litigation exposures." It said the deal would be funded through existing borrowing facilities and cash generation. Separately, Indivior also raised its full-year profit and revenue guidance after Suboxone lost market share at a slower pace than expected. Its shares closed 6.73% higher. Claim: Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes.
Example Output:
Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment.